Proporción de casos BI-RADS 4 y 5 en mujeres mayores de 40 años que acudieron a realizarse mastografía posterior a las restricciones por COVID-19 en la UMF Plus/UMAA 7 en comparación con 2019

Revista Mexicana de Medicina Familiar Pub Date : 2024-07-17 DOI:10.24875/rmf.24000021

María F. Saldívar-Cavazos, José C. Álvarez-Contreras, N. Álvarez-Villalobos

{"title":"Proporción de casos BI-RADS 4 y 5 en mujeres mayores de 40 años que acudieron a realizarse mastografía posterior a las restricciones por COVID-19 en la UMF Plus/UMAA 7 en comparación con 2019","authors":"María F. Saldívar-Cavazos, José C. Álvarez-Contreras, N. Álvarez-Villalobos","doi":"10.24875/rmf.24000021","DOIUrl":null,"url":null,"abstract":": Background: In 2020, the World Health Organization declared the COVID-19 a pandemic, suspending screening programs, affecting timely detection of breast cancer worldwide, leading to an increase in cases in the post-pandemic period. Objective: To determine the proportion of BI-RADS 4 and 5 cases in mammograms performed after COVID-19 restrictions compared to those in 2019. Materials and methods: Observational, cross-sectional, and comparative study of patients with BI-RADS 4 or 5 mammograms after COVID-19 restrictions compared to those in 2019 at a family medicine unit. Results: Out of a total of 5 945 mammograms, 2 415 were performed in 2019 and 3 530 in 2022. In 2019, 69 were classified as BI-RADS > 4 (2.85%), and in 2022 this increased to 175 (4.95%) (p = 0.001). This increase was proportional for all age groups (p < 0.045). Conclusions: A 73% increase in mammograms classified as BI-RADS 4 or 5 was observed in the year following the pandemic, compared to the year before it.","PeriodicalId":34592,"journal":{"name":"Revista Mexicana de Medicina Familiar","volume":"23 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Mexicana de Medicina Familiar","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/rmf.24000021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

: Background: In 2020, the World Health Organization declared the COVID-19 a pandemic, suspending screening programs, affecting timely detection of breast cancer worldwide, leading to an increase in cases in the post-pandemic period. Objective: To determine the proportion of BI-RADS 4 and 5 cases in mammograms performed after COVID-19 restrictions compared to those in 2019. Materials and methods: Observational, cross-sectional, and comparative study of patients with BI-RADS 4 or 5 mammograms after COVID-19 restrictions compared to those in 2019 at a family medicine unit. Results: Out of a total of 5 945 mammograms, 2 415 were performed in 2019 and 3 530 in 2022. In 2019, 69 were classified as BI-RADS > 4 (2.85%), and in 2022 this increased to 175 (4.95%) (p = 0.001). This increase was proportional for all age groups (p < 0.045). Conclusions: A 73% increase in mammograms classified as BI-RADS 4 or 5 was observed in the year following the pandemic, compared to the year before it.

查看原文本刊更多论文

与 2019 年相比，UMF Plus/UMAA 7 在 COVID-19 限制后，40 岁以上女性接受乳腺 X 光检查的 BI-RADS 4 和 5 例比例。

:背景：2020 年，世界卫生组织宣布 COVID-19 为大流行病，暂停筛查计划，影响了全球乳腺癌的及时发现，导致流行病后病例增加。研究目的确定与2019年相比，COVID-19限制后进行的乳房X光检查中BI-RADS 4和5病例的比例。材料和方法：观察性、横断面和比较研究：在一家家庭医疗单位，COVID-19 限制后与 2019 年相比，BI-RADS 4 或 5 乳房 X 光检查患者的情况。研究结果在总共 5 945 例乳房 X 光检查中，2019 年进行了 2 415 例，2022 年进行了 3 530 例。2019 年，69 例被归类为 BI-RADS > 4（2.85%），2022 年增至 175 例（4.95%）（p = 0.001）。这一增长在所有年龄组中都是成比例的（p < 0.045）。结论与疫情发生前一年相比，疫情发生后一年被列为BI-RADS 4或5级的乳房X光检查增加了73%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Mexicana de Medicina Familiar

自引率

0.00%

发文量

审稿时长

18 weeks